Status:
COMPLETED
An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF
Lead Sponsor:
MedImmune LLC
Collaborating Sponsors:
AstraZeneca
Conditions:
Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure
Eligibility:
All Genders
50+ years
Brief Summary
The primary objective of this observational study is to determine the incidence of medically attended (inpatient or outpatient) acute respiratory illnesses or events leading to worsening cardiorespira...
Detailed Description
It is expected that this observational study will provide further understanding of the clinical impact and true incidence rates of RSV-associated hospitalizations and medically attended acute respirat...
Eligibility Criteria
Inclusion
- Key
- Age 50 years or greater
- Hospitalization due to worsening COPD and/or CHF
- Severe COPD subjects (Global Initiative for Obstructive Lung Disease Stage III/IV); FEV1 \<50%
- Chronic CHF subjects (New York Heart Association Class III/IV or American College of Cardiology-American Heart Association Stage C/D); Ejection fraction \< 40%
- Expects to have direct contact with children at least once a month
- Key
Exclusion
- \- Participation in another clinical study involving the use of investigational product
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
476 Patients enrolled
Trial Details
Trial ID
NCT01455402
Start Date
July 1 2010
End Date
May 1 2014
Last Update
July 9 2014
Active Locations (60)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Birmingham, Alabama, United States, 35294
2
Research Site
Fort Smith, Arkansas, United States, 72901
3
Research Site
Denver, Colorado, United States
4
Research Site
Bay Pines, Florida, United States